Jermasek Douglas Insider Trades

Insider Trading History

Track insider trading activity for Jermasek Douglas. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Unicycive Therapeutics
Unicycive Therapeutics UNCY
Evp, Corporate Strategy
Holding Value $1.22M 169,500 shares
Last Trade
May 14, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.45M 169,500 shares
$8.56
$7.20
Unicycive Therapeutics
Unicycive Therapeutics UNCY
EVP Of Corporate Strategy
Holding Value $1.55M 215,500 shares
Last Trade
Jul 28, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$47.1k 10,000 shares
$4.71
$7.20
Unicycive Therapeutics
Unicycive Therapeutics UNCY
EVP Of Corporate Strategy
Holding Value $14.8M 2,055,000 shares
Last Trade
Aug 12, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$281k 81,750 shares
$3.44
$7.20
Unicycive Therapeutics
Unicycive Therapeutics UNCY
EVP Of Corporate Strategy
Holding Value $14.2M 1,973,250 shares
Last Trade
Apr 15, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.28M 463,250 shares
$11.40
$7.20
Unicycive Therapeutics
Unicycive Therapeutics UNCY
EVP Of Corporate Strategy
Holding Value $10.9M 1,510,000 shares
Last Trade
Aug 28, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.2M 1,355,000 shares
$7.50
$7.20
Unicycive Therapeutics
Unicycive Therapeutics UNCY
EVP Of Corporate Strategy
Holding Value $1.26M 175,012 shares
Last Trade
Jul 11, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$4.53M 371,186 shares
$12.20
$7.20
Unicycive Therapeutics
Unicycive Therapeutics UNCY
EVP Of Corporate Strategy
Holding Value $0 0 shares
Last Trade
Jul 11, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$610 50 shares
$12.20
$7.20
Unicycive Therapeutics
Unicycive Therapeutics UNCY
EVP Of Corporate Strategy
Holding Value $360 50 shares
Last Trade
Mar 08, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$810 50 shares
$16.20
$7.20
Unicycive Therapeutics
Unicycive Therapeutics UNCY
EVP Of Corporate Strategy
Holding Value $1.12M 155,000 shares
Last Trade
Nov 21, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$413k 55,000 shares
$7.50
$7.20
Unicycive Therapeutics
Unicycive Therapeutics UNCY
Director
Holding Value $0 0 shares
Last Trade
Nov 18, 2022 Sale
$740k 100,000 shares
$7.40
$7.20

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up